Cargando…
Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer
Autores principales: | Gordian, Edna, Welsh, Eric A., Gimbrone, Nicholas, Siegel, Erin M., Shibata, David, Creelan, Ben C., Cress, William Douglas, Eschrich, Steven A., Haura, Eric B., Muñoz-Antonia, Teresita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238243/ https://www.ncbi.nlm.nih.gov/pubmed/34194632 http://dx.doi.org/10.18632/oncotarget.28004 |
Ejemplares similares
-
Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer
por: Gordian, Edna, et al.
Publicado: (2019) -
Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer
por: Gordian, Edna, et al.
Publicado: (2014) -
Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes
por: Hudson, Janella, et al.
Publicado: (2016) -
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model
por: Sarcar, Bhaswati, et al.
Publicado: (2019) -
Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma
por: Chen, Lu, et al.
Publicado: (2016)